European neurological review最新文献_第9页

Advances in Atrial Fibrillation-related Stroke Prevention 房颤相关脑卒中预防研究进展

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2014.09.02.122

P. Amarenco, W. Hacke, B. Norrving, N. Rost

引用次数: 0

Selective Attention and Mental Flexibility are Reduced during the Interictal Period in Migraine 选择性注意力和心理灵活性在偏头痛的间歇期降低

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2015.10.02.204

F. Yannick, Kamgang Fogoum Alain, N. Moustapha, D. Gallo, N. M. Mansour

{"title":"Selective Attention and Mental Flexibility are Reduced during the Interictal Period in Migraine","authors":"F. Yannick, Kamgang Fogoum Alain, N. Moustapha, D. Gallo, N. M. Mansour","doi":"10.17925/ENR.2015.10.02.204","DOIUrl":"https://doi.org/10.17925/ENR.2015.10.02.204","url":null,"abstract":"Background: Headache patients frequently complain about difficulties in attention and concentration, even when they are headache free, and psychometric studies concerning attentional deficits in migraine patients between attacks are scarce. Objective: To evaluate selective attention of migraine patients interictally and compare them with healthy volunteers. Patients and Methods: We performed, between February 2011 and July 2011, a case-control study including 45 university students suffering from migraine matched with 45 healthy students as controls. Migraine patients were evaluated in an interictal state. Subjects with another headache type, history of brain injury, epilepsy and visual disturbances were excluded. Mood disorders were assessed using the Hospital Anxiety and Depression (HAD) questionnaire. Selective attention was evaluated using the Delis–Kaplan Executive Functions System (D-KEFS) colour-word interference test. Results: Mean age of patients was 23.29±2.55 years, versus 22.89±2.04 years for controls (p=0.2). The selective attention score was −4.04±7.08 for patients, versus −1.31±7.73 for controls (p=0.02). The mean mental flexibility score was lower in migraine patients compared with controls (36.67±6.79 versus 41.33±6.23; p=0.01). Gender, anxiety, depression scores and migraine characteristics had no correlation with the selective attention score. Conclusion: Selective attention and mental flexibility capacities are significantly reduced in migraine patients during the interictal period. These abnormalities probably contribute to frequent attentional complaints among these patients.","PeriodicalId":12047,"journal":{"name":"European neurological review","volume":"114 1","pages":"204"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67591632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Erratum to: Effect of Therapeutic Interventions on Health-related Quality of Life in Parkinson’s Disease 治疗干预对帕金森病患者健康相关生活质量的影响

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2014.09.02.156

H. Reichmann, P. Martínez-Martín, F. Stocchi

引用次数: 0

European Academy of Neurology (EAN) The First Congress Is Approaching 欧洲神经病学学会(EAN)第一次代表大会即将召开

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2015.10.01.10

A. Sauerbier

引用次数: 0

Vitamin D Deficiency and Possible Role in Multiple Sclerosis 维生素D缺乏及其在多发性硬化中的可能作用

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2015.10.02.131

M. Holick, S. Cook, G. Suárez, M. Rametta

{"title":"Vitamin D Deficiency and Possible Role in Multiple Sclerosis","authors":"M. Holick, S. Cook, G. Suárez, M. Rametta","doi":"10.17925/ENR.2015.10.02.131","DOIUrl":"https://doi.org/10.17925/ENR.2015.10.02.131","url":null,"abstract":"TOUCH MEDICAL MEDIA • Despite a lack of consensus, vitamin D deficiency and insufficiency have been defined as a serum level of 25-hydroxyvitamin D (25[OH]D) <50 nmol/L or 52.5–72.5 nmol/L respectively. • Vitamin D deficiency is widespread. • Vitamin D is probably involved in the prevention of numerous disease states. • Most primary care clinicians are unaware of the recommended dose for vitamin D supplementation or the optimum serum level in multiple sclerosis (MS) patients. • In the general population management of vitamin D deficiency in children and adults can be effectively achieved by administering 50,000 IU vitamin D2 or vitamin D3 once a week for 6 or 8 weeks respectively: – In the general population 600–1,000 IU/d is effective to prevent recurrence in children and 50,000 IU vitamin D3 or vitamin D2 every 2 weeks (equivalent to approximately 3,600 IU daily) in adults. This strategy maintains blood levels of 25(OH)D at approximately 100–150 nmol/L for up to 6 years with no evidence of toxicity. – In pregnant women supplementation with 2,000 and 4,000 IU/d during pregnancy improve maternal/ neonatal vitamin D status. • Considerable evidence exists for the protective effects of vitamin D in MS, with higher sun exposure and vitamin D intake associated with a lower risk of MS. • Improvement in 25(OH)D status appears to additively enhance the beneficial effects of interferon-beta. To date, this effect has not as yet been observed with glatiramer acetate. • Results from the Betaferon/Betaseron in Newly Emerging multiple sclerosis For Initial Treatment (BENEFIT) study showed that patients with vitamin D levels (25[OH]D) <50 nmol/L had more prominent clinical and MRI disease activity.","PeriodicalId":12047,"journal":{"name":"European neurological review","volume":"10 1","pages":"131"},"PeriodicalIF":0.0,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67591262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Cognitive Impairment in Multiple Sclerosis 多发性硬化症的认知障碍

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2015.10.02.157

T. Santos, J. Pinheiro, P. Barros

引用次数: 2

New Directions in Research and Therapies in Traumatic Brain Injury 外伤性脑损伤研究与治疗新方向

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2015.10.01.56

J. Thome, D. Muresanu

引用次数: 1

Optimising Epilepsy Therapy – Searching for the Evidence – Looking Beyond the Data 优化癫痫治疗-寻找证据-超越数据

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2015.10.02.164

M. Carreño, E. Trinka, M. Holtkamp

引用次数: 0

Treating drug-resistant epilepsy - Why are we waiting? 治疗耐药癫痫——我们为什么还要等待?

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2015.10.02.171

P. Boon, P. Ryvlin, J. Wheless, K. Kawai

引用次数: 2

Neuroplasticity – Basis for Lifelong Learning 神经可塑性——终身学习的基础

European neurological review Pub Date : 2015-01-01 DOI: 10.17925/ENR.2014.09.02.143

J. Kesselring

引用次数: 1